The future of MRI in radiation therapy: Challenges and opportunities for the MR community Review


Authors: Goodburn, R. J.; Philippens, M. E. P.; Lefebvre, T. L.; Khalifa, A.; Bruijnen, T.; Freedman, J. N.; Waddington, D. E. J.; Younus, E.; Aliotta, E.; Meliadò€, G.; Stanescu, T.; Bano, W.; Fatemi-Ardekani, A.; Wetscherek, A.; Oelfke, U.; van den Berg, N.; Mason, R. P.; van Houdt, P. J.; Balter, J. M.; Gurney-Champion, O. J.
Review Title: The future of MRI in radiation therapy: Challenges and opportunities for the MR community
Abstract: Radiation therapy is a major component of cancer treatment pathways worldwide. The main aim of this treatment is to achieve tumor control through the delivery of ionizing radiation while preserving healthy tissues for minimal radiation toxicity. Because radiation therapy relies on accurate localization of the target and surrounding tissues, imaging plays a crucial role throughout the treatment chain. In the treatment planning phase, radiological images are essential for defining target volumes and organs-at-risk, as well as providing elemental composition (e.g., electron density) information for radiation dose calculations. At treatment, onboard imaging informs patient setup and could be used to guide radiation dose placement for sites affected by motion. Imaging is also an important tool for treatment response assessment and treatment plan adaptation. MRI, with its excellent soft tissue contrast and capacity to probe functional tissue properties, holds great untapped potential for transforming treatment paradigms in radiation therapy. The MR in Radiation Therapy ISMRM Study Group was established to provide a forum within the MR community to discuss the unmet needs and fuel opportunities for further advancement of MRI for radiation therapy applications. During the summer of 2021, the study group organized its first virtual workshop, attended by a diverse international group of clinicians, scientists, and clinical physicists, to explore our predictions for the future of MRI in radiation therapy for the next 25 years. This article reviews the main findings from the event and considers the opportunities and challenges of reaching our vision for the future in this expanding field. © 2022 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.
Keywords: treatment response; treatment planning; cancer radiotherapy; nuclear magnetic resonance imaging; magnetic resonance imaging; neoplasm; neoplasms; biological marker; computer assisted tomography; image analysis; radiotherapy; clinical protocol; diagnostic imaging; prediction; histology; dosimetry; medical research; magnetic resonance; ionizing radiation; radiation therapy; radiotherapy planning, computer-assisted; motion; tissue; radiation toxicity; process optimization; image guided radiotherapy; procedures; mr; future; tumor control; organs at risk; hypofractionated radiotherapy; disease burden; healthy tissues; humans; prognosis; human; article; radiotherapy planning system; tissue imaging; study groups; localisation; ismrm workshop; four-dimensional imaging
Journal Title: Magnetic Resonance in Medicine
Volume: 88
Issue: 6
ISSN: 0740-3194
Publisher: John Wiley & Sons  
Date Published: 2022-12-01
Start Page: 2592
End Page: 2608
Language: English
DOI: 10.1002/mrm.29450
PUBMED: 36128894
PROVIDER: scopus
PMCID: PMC9529952
DOI/URL:
Notes: Article -- Export Date: 1 November 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric Aliotta
    14 Aliotta